IVI and Papua New Guinea

 

Member State Relations

 

On November 26, 1996, the Permanent Representative of Papua New Guinea to the United Nations, H.E. Utula Utuoc Samana, signed the IVI Establishment Agreement.

 

Ongoing Collaboration

 

Capturing data on Antimicrobial resistance Patterns and Trends in Use in Regions of Asia (CAPTURA)

The IVI-led CAPTURA project played a pivotal role in expanding historical and current datasets on AMR and antimicrobial usage through extensive data collection efforts across Southeast and South Asia. Building on its successes, CAPTURA II aims to further improve the quality, quantity, analysis, and dissemination of AMR data. This phase focuses on refining methodologies in data collection, stronger monitoring of how surveillance systems are performing, better data management practices, and supporting sustainable improvements in these surveillance systems.

 

The project runs from 2023 through 2025, directly informing national and regional initiatives to help:

  1. Improve AMR surveillance
  2. Promote antimicrobial stewardship
  3. Shape evidence-based policy

 

Countries: Bangladesh, Bhutan, Indonesia, Laos, Nepal, Pakistan, Papua New Guinea, Sri Lanka, Viet Nam

 

Strengthening External Quality Assurance for AMR in Asia (EQAsia)

The Technical University of Denmark is leading a consortium with IVI and the Veterinary Faculty at Chulalongkorn University in Thailand with the Strengthening External Quality Assurance for AMR in Asia (EQAsia) project. During the first phase, the consortium identified and mapped coverage of external quality assurance programs on the continent, providing seven rounds of services and relevant trainings to National Reference Laboratories and Centers of Excellence across One Health sectors. In the next phase, launched in 2023, partners provide four additional rounds of external quality assurance to more than 80 laboratories and centers in Asia and support two countries in establishing national external quality assurance programs to build up their capacity to independently conduct One Health-focused external quality assurance.

 

Technical Assistance for Clinical Engagement – Asia (TACE Asia)

The TACE Asia project focuses on providing technical support to improve the use of laboratory services and generation of good quality and representative AMR and antimicrobial use data in the human health sector. This will be done through support for clinical engagement and training on the use of simplified protocols to generate AMR burden data in select Fleming Fund priority countries. Launched in 2024, the program is contributing to the use of data on clinical practice and decision-making, improving rational use of antimicrobials, promoting antimicrobial stewardship, and shaping evidence-based practice.

 

Countries: Bangladesh, Bhutan, Indonesia, Laos, Nepal, Pakistan, Papua New Guinea, Sri Lanka, Timor-Leste, Viet Nam